Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-09-07 00:00:00 ET · period of report 2022-09-02 · accession 0001209191-22-049023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-07 | 2022-09-02 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | F - Tax | $26.38 | -865 | 13.8K | -6% | -$22.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-02 | F | D | 865 | $26.38 | 13,822 | D | — | — |